Nanoparticles of folic acid‐methyl‐β‐cyclodextrin (FA‐MβCD)/adamantane‐albumin exhibit enhanced antitumor activity compared with FA‐MβCD alone

Supramolecular drug carriers are a promising approach for delivering anticancer drugs with high blood retention after administration. We previously synthesized folic acid‐modified methyl‐β‐cyclodextrin (FA‐MβCD) as an anticancer drug. FA‐MβCD has a selective autophagy‐mediated antitumor effect on fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Aiko, Yamashita, Yuki, Misumi, Shogo, Kishimoto, Naoki, Onodera, Risako, Higashi, Taishi, Arima, Hidetoshi, Motoyama, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900082/
https://www.ncbi.nlm.nih.gov/pubmed/36537756
http://dx.doi.org/10.1002/2211-5463.13540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900082/
https://www.ncbi.nlm.nih.gov/pubmed/36537756
http://dx.doi.org/10.1002/2211-5463.13540

Ejemplares similares